EVAR requires more late secondary vascular interventions than open AAA repair, but patients who undergo open repair have more nonvascular long-term morbidity. Long-term survival is better after EVAR compared to open repair in this selected patient group.
A chytrid first discovered in Mediterranean sands and called Rhizophlyctis harderi was classified in the genus Rhizophlyctis based on its interbiotic vegetative thalli with multiple rhizoidal axes and resting thalli with tufts of rhizoid-like appendages. Developmental, electron microscopic and molecular analyses, however, have brought into question the proper placement of this chytrid. Because its original description was in German and not Latin, the name R. harderi is not validly published. We found that this chytrid produces three thallus forms that could place it in three different morpho-genera: Rhizophydium, Phlyctochytrium or Rhizophlyctis. The ultrastructural architecture of its zoospore is different from that of zoospores of Rhizophlyctis rosea, the type species for Rhizophlyctis, and shares zoospore ultrastructural characteristics with the Rhizophydiales. Zoospores of this chytrid exhibit a distinctive kinetosome-associated structure (KAS), a curved shield bridged to two of the kinetosomal triplets and a layered cap anterior to the kinetosome. Phylogenetic analyses of nuc rDNA also support the placement of this chytrid in the Rhizophydiales and not in the Rhizophlyctidales. Given its molecularly based phylogenetic placement and its distinctive zoospore architecture, we describe this chytrid in a new genus, Uebelmesseromyces, in the Rhizophydiales and erect Uebelmesseromycetaceae as a new family to accommodate it.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.